News | June 29, 2024
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Subscribe To Our Newsletter & Stay Updated
